Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $733.47 | 34 | 91.2% |
| Education | $70.88 | 2 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $366.81 | 14 | $0 (2018) |
| Janssen Biotech, Inc. | $158.52 | 8 | $0 (2018) |
| Merz North America, Inc. | $86.49 | 3 | $0 (2022) |
| ABBVIE INC. | $47.09 | 2 | $0 (2022) |
| Solta Medical, a division of Bausch Health US, LLC | $22.51 | 1 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $20.44 | 1 | $0 (2021) |
| Arcutis Biotherapeutics, Inc. | $19.66 | 1 | $0 (2023) |
| Aclaris Therapeutics, Inc. | $15.60 | 1 | $0 (2019) |
| Amgen Inc. | $15.47 | 1 | $0 (2024) |
| Lilly USA, LLC | $13.78 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.47 | 1 | Amgen Inc. ($15.47) |
| 2023 | $33.07 | 2 | Arcutis Biotherapeutics, Inc. ($19.66) |
| 2022 | $86.08 | 4 | Merz North America, Inc. ($25.94) |
| 2021 | $45.75 | 3 | Nestle HealthCare Nutrition Inc. ($20.44) |
| 2020 | $34.17 | 1 | MERZ NORTH AMERICA, INC. ($34.17) |
| 2019 | $15.60 | 1 | Aclaris Therapeutics, Inc. ($15.60) |
| 2018 | $240.41 | 11 | PFIZER INC. ($144.04) |
| 2017 | $333.80 | 13 | PFIZER INC. ($222.77) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Inflammation | ||||||
| 06/27/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.66 | General |
| 04/11/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.41 | General |
| Category: Immunology | ||||||
| 12/22/2022 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $22.51 | General |
| 05/19/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $25.94 | General |
| 09/25/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Immunology | ||||||
| 06/25/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Diabetes | ||||||
| 09/24/2020 | MERZ NORTH AMERICA, INC. | XEOMIN (Biological), ASCLERA | Food and Beverage | Cash or cash equivalent | $34.17 | General |
| Category: DERMATOLOGY | ||||||
| 07/25/2019 | Aclaris Therapeutics, Inc. | RHOFADE (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $26.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $72.88 | General |
| Category: DERMATOLOGY | ||||||
| 07/25/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 06/13/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: DERMATOLOGY | ||||||
| 05/23/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: DERMATOLOGY | ||||||
| 05/23/2018 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Immunology | ||||||
| 05/09/2018 | PFIZER INC. | XELJANZ (Drug) | Education | In-kind items and services | $0.89 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/02/2018 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Immunology | ||||||
| 04/04/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: DERMATOLOGY | ||||||
| 03/03/2018 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 01/18/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: DERMATOLOGY | ||||||
| 12/28/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: DERMATOLOGY | ||||||
| 12/15/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,643 | 6,241 | $1.2M | $263,857 |
| 2022 | 25 | 2,350 | 3,861 | $1.1M | $229,175 |
| 2021 | 20 | 956 | 1,451 | $853,470 | $172,769 |
| 2020 | 16 | 760 | 1,165 | $646,591 | $131,619 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,854 | 3,293 | $363,747 | $91,445 | 25.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 66 | 80 | $169,762 | $37,963 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 267 | $73,913 | $15,981 | 21.6% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 27 | 29 | $57,747 | $13,981 | 24.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 23 | 35 | $45,196 | $12,051 | 26.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 255 | 298 | $62,535 | $10,702 | 17.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 97 | 107 | $38,020 | $8,388 | 22.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 35 | 36 | $53,118 | $7,453 | 14.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 174 | 201 | $35,073 | $7,186 | 20.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 32 | 33 | $43,911 | $6,708 | 15.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 95 | 108 | $24,327 | $6,472 | 26.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 77 | 86 | $23,641 | $6,140 | 26.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 81 | 123 | $22,969 | $6,084 | 26.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 98 | 107 | $34,098 | $6,053 | 17.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 211 | 1,095 | $23,152 | $5,282 | 22.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 40 | 42 | $22,270 | $5,150 | 23.1% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $19,954 | $4,320 | 21.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 63 | 102 | $10,201 | $2,694 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $15,065 | $2,676 | 17.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 35 | $5,526 | $1,384 | 25.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $9,181 | $1,330 | 14.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 13 | $5,153 | $1,189 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 15 | $5,873 | $1,110 | 18.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 37 | 37 | $8,215 | $1,013 | 12.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 12 | 14 | $4,494 | $744.49 | 16.6% |
About Dr. Brooke Walls, DO
Dr. Brooke Walls, DO is a MOHS-Micrographic Surgery healthcare provider based in Aspen, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205161478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brooke Walls, DO has received a total of $804.35 in payments from pharmaceutical and medical device companies, with $15.47 received in 2024. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($733.47).
As a Medicare-enrolled provider, Walls has provided services to 7,709 Medicare beneficiaries, totaling 12,718 services with total Medicare billing of $797,420. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Aspen, CO
- Active Since 10/06/2009
- Last Updated 02/24/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1205161478
Products in Payments
- EUCRISA (Drug) $365.92
- STELARA (Biological) $111.03
- XEOMIN (Biological) $60.55
- Tremfya (Drug) $47.49
- RINVOQ (Biological) $24.59
- Humira (Biological) $22.50
- ZENPEP (Drug) $20.44
- RHOFADE (Drug) $15.60
- Otezla (Drug) $15.47
- TALTZ (Drug) $13.78
- Sotyktu (Drug) $13.41
- ADBRY (Biological) $13.04
- Ozempic (Drug) $11.53
- XELJANZ (Drug) $0.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.